EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Endobronchial Pulmonary Actinomycosis With Concomitant Tuberculosis Resembling Lung Malignancy on Presentation: A Case Report

Safal Bogati, Bishal Pradhan, Suraksha Thapa, Milesh Jung Sijapati, Prabhas Joshi, Richa Ghimire, Samikchhya Regmi

Respirology Case Reports · 2026-11 · 14 (11)

DOI: 10.1002/rcr2.70813 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Pulmonary actinomycosis is a rare, indolent infection accounting for roughly 15% of actinomycosis cases, frequently misdiagnosed as tuberculosis or malignancy owing to nonspecific clinical and radiological features. We report a 68‐year‐old male smoker with chronic alcohol use who presented with acute‐on‐chronic dyspnea, cough, and fever. Imaging revealed cavitary lesions, consolidation, ground‐glass opacities, and mediastinal lymphadenopathy suggestive of tuberculosis or malignancy. Sputum and initial microbiological workup for tuberculosis were largely negative, though a low‐level bronchoalveolar lavage GeneXpert signal prompted empirical anti‐tubercular therapy. Bronchoscopy revealed an endobronchial mass, and biopsy demonstrated pathognomonic sulfur granules composed of PAS‐positive filamentous organisms, confirming actinomycosis with no malignant cells. The patient was treated with amoxicillin‐clavulanate alongside continued anti‐tubercular therapy, with symptomatic improvement. This case highlights actinomycosis as a condition requiring a high index of suspicion when mimicking tuberculosis and lung cancer, reinforcing the necessity of histopathological confirmation for accurate diagnosis and guiding prolonged, appropriate antimicrobial management.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →